MN HF1183 | 2021-2022 | 92nd Legislature
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on February 18 2021 - 25% progression, died in committee
Action: 2021-04-09 - Author stricken Boe
Pending: House Ways and Means Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Introduced on February 18 2021 - 25% progression, died in committee
Action: 2021-04-09 - Author stricken Boe
Pending: House Ways and Means Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
Title
Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2021-04-09 | House | Author stricken Boe |
| 2021-03-25 | House | Author added Greenman |
| 2021-03-11 | House | Committee report, to adopt and re-refer to Ways and Means |
| 2021-03-08 | House | Author added Klevorn |
| 2021-03-04 | House | Author added Bierman |
| 2021-03-04 | House | Committee report, to adopt as amended and re-refer to State Government Finance and Elections |
| 2021-02-25 | House | Author added Boe |
| 2021-02-25 | House | Committee report, to adopt as amended and re-refer to Health Finance and Policy |
| 2021-02-18 | House | Introduction and first reading, referred to Commerce Finance and Policy |
Same As/Similar To
SF1265 (Similar To) 2021-03-01 - Author added Hoffman
